The Middle East and Africa Enteral Feeding Devices Market was worth USD 0.18 billion in 2022 and estimated to be growing at a CAGR of 4.197%, to reach USD 0.22 billion by 2027. Enteral nutrition is growingly being accepted as an effective system of clinical nutrition.
A shift in the MEA enteral feeding market from routine hospital care to home setting / non-clinical enteral nutrition is increasing and has been significant in the healthcare sector. The rising costs of hospital stays have often forced clinicians involved in patients requiring nutritional support for long periods of time to encourage patients to adopt enteral nutrition at home.
Several countries, such as UAE, Bahrain, Turkey, and Egypt, have established nutrition teams that support patients receiving enteral nutrition at home. Therefore, the demand for enteral nutrition positively impacts the MEA market, and this shift is seen in many MEA developed regions than in MEA developing regions.
According to the United Nations Department of Economic and Social Affairs, the elderly made up 12.7% of the world's population in 2014. Age-related conditions such as diabetes, vascular disease, stroke, cancer, dementia, arthritis, osteoporosis, circulatory failure, and Parkinson's disease are on the rise, driving the growth of the enteral feeding devices market. Despite the growing acceptance of enteral feeding devices, currently accepted procedures include the initial placement of a G-tube for a patient to be performed using a surgical G-tube or a PEG device. Once the stoma has healed, the patient tube can be replaced with a push-button device. These technological advancements are leading the way for improving customer satisfaction, which is essential for the growth of the MEA enteral feeding devices market.
However, certain factors such as reimbursements issues for enteral feeding in most developing countries in the Middle East and Africa are insufficient. This is considered a major challenge for the widespread growth of enteral feeding in most developing countries in the MEA region. In addition, declining federal funding and subsequent reductions in reimbursements for home care services over the next five years are expected to address the challenges facing players in the MEA enteral feeding devices market.
This research report on the Middle East and Africa enteral feeding devices market has been segmented and sub-segmented into the following categories:
By Product Type:
By End User:
The enteral feeding devices market in the African region is estimated to grow at the highest CAGR during the forecast period in the MEA region. Many factors driving the market growth include a growing aging population, increased awareness of enteral nutrition, a greater number of premature births and rapid development of healthcare facilities, etc. As a result, major players have turned to emerging economies in these regions and are focusing on expansions and acquisitions to gain greater market share in the years to come.
Besides, the players in the Middle East market are more effectively dominating the growth of the market while bringing significant developments in the techniques of manufacturing products and the method of performing the task, further increasing the demand and leading to the growth of the market in more effective over the years to come. Therefore, many Middle East countries are expected to have good lucrative growth opportunities in the forecasted period.
KEY MARKET PLAYERS:
Companies that have a presence in the MEA Enteral Feeding Devices Market profiled in this report are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org